Evidence map›Paper›PMID 31101667›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

Phosphorylation at S2053 in Murine (S2056 in Human) DNA-PKcs Is Dispensable for Lymphocyte Development and Class Switch Recombination.

Wenxia Jiang, Verna M Estes, Xiaobin S Wang, Zhengping Shao, Brian J Lee, Xiaohui Lin, Jennifer L Crowe, Shan Zha

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. When DNA-damage responses meet innate and adaptive immunity.Cellular and molecular life sciences : CMLS · 2024
    Review
  11. Biomolecules · 2024
    Article
  12. Article
  13. Phosphorylation of DNA-PKcs at the S2056 cluster ensures efficient and productive lymphocyte development in XLF-deficient mice.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Wenxia JiangInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032.ORCID 0000-0002-5097-0975
Verna M EstesInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Xiaobin S WangInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Zhengping ShaoInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Brian J LeeInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Xiaohui LinInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032.ORCID 0000-0002-8265-0474
Jennifer L CroweInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032.
Shan ZhaInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032; sz2296@columbia.edu.ORCID 0000-0002-6568-1818
Cancer Genetics (United States) · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3M
The Role of CTIP in Lymphocyte Development and LymphomagenesisP01CA174653 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GAUTIER, JEAN · 2014 to 2024
$17.6M
CELL, MOLECULAR AND DEVELOPMENTAL BIOLOGY OF CANCERT32CA009503 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI GAUTIER, JEAN · 1985 to 2016
$6.8M
The role of ATM in the suppression of lymphoid malignancyR01CA158073 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Shan Zha · 2011 to 2026
$5.7M
The structural function of ATR in development, oncogenesis and cancer therapyR01CA215067 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHA, SHAN · 2017 to 2021
$1.9M
DNA-PKCS Phosphorylation in DNA Repair and Chromosomal TranslocationsR01CA184187 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHA, SHAN · 2015 to 2019
$1.8M
The catalytic and non-catalytic functions of PARP1 in cancer biologyR01CA226852 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHA, SHAN · 2018 to 2022
$1.8M
Clinical and Translational Science AwardTL1TR000082 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$732k
Non-catalytic functions of DNA-PK in DNA repair and tumorigenesisF31CA183504 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CROWE, JENNIFER L · 2014 to 2016
$129k
NCATS NIH HHS TL1 TR000082NCI NIH HHS F31 CA183504NCI NIH HHS P01 CA174653NCI NIH HHS P30 CA013696NCI NIH HHS R01 CA158073NCI NIH HHS R01 CA184187NCI NIH HHS R01 CA215067NCI NIH HHS R01 CA226852NCI NIH HHS T32 CA009503
6 · The paper itself

Abstract

The classical nonhomologous end-joining (cNHEJ) pathway is a major DNA double-strand break repair pathway in mammalian cells and is required for lymphocyte development and maturation. The DNA-dependent protein kinase (DNA-PK) is a cNHEJ factor that encompasses the Ku70-Ku80 (KU) heterodimer and the large DNA-PK catalytic subunit (DNA-PKcs). In mouse models, loss of DNA-PKcs (

Indexed as

AnimalsCell DifferentiationCell LineDNA-Activated Protein KinaseDNA-Binding ProteinsFibroblastsGene Knock-In TechniquesHumansImmunoglobulin Class SwitchingLymphocyte ActivationLymphocytesMiceMice, KnockoutMutationRadiation ToleranceSerineDNA-Activated Protein KinaseDNA-Binding ProteinsPrkdc protein, mouseSerine

Identifiers

PMID31101667
PMCPMC6581594
OpenAlexW2946302178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.